Back to News
Market Impact: 0.22
Investors pour over $30bn into longevity biotech as report predicts longevity drugs from 2035
Source: PR Newswire
Healthcare & BiotechPrivate Markets & VentureCompany Fundamentals
Global investment in longevity biotech reached a record $18.4bn in 2025, nearly quadrupling from $4.7bn in 2024, while $12.1bn has already been invested in 2026. Longevity.Technology forecasts the sector could become a $617bn market by 2045, signaling strong investor interest and long-term growth potential for aging-related biotech.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
More News
- Japan’s corporate leaders sound alarm over weak yen — even dollar-earners are voicing concerns
- Why is Weichai Power stock rallying today?
- Fed hikes again - an AI-Picked insurer is still cashing in
- Berkshire May Boost Japan Trading House Holdings, Itochu Says
- Status Of Anthropic IPO As AI Fears Mount
- Why is Sumitomo stock climbing today?